Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1996
12/17/1996US5585351 T-cadherin adhesion molecule
12/17/1996US5585350 Thrombin-inhibitory protein from ticks
12/17/1996US5585349 Method of treating viral infections
12/17/1996US5585348 Administering antagonists before or during treatment, reduced side effects
12/17/1996US5585347 Measuring prolactin level in blood at spaced intervals during subjects waking and sleeping periods over twenty four hours to create a profile; comparing to control
12/17/1996US5585346 Blocking superoxide production in phagocytic cells; antiinflammatory agents; gout; autoimmune disorders; myocardial infarction; respiratory and skin disorders
12/17/1996US5585345 CTP extended form of glycoprotein hormones
12/17/1996US5585344 Liver-derived receptors for advanced glycosylation endproducts and uses thereof
12/17/1996US5585270 Polynucleotides encoding connective tissue growth factor
12/17/1996US5585269 Nucleotide sequence which encodes a receptor having tyrosine kinase activity
12/17/1996US5585259 Ecotin as a factor Xa, XIa, and XIIa inhibitor
12/17/1996US5585258 Hepatitis C virus protease
12/17/1996US5585254 Autonomous parvovirus gene delivery vehicles and expression vectors
12/17/1996US5585239 Herpes simplex virus drug screen
12/17/1996US5585234 Treatment of infertile sperm in vitro with thymosin α1 to enhance penetration of mammalian ova
12/17/1996US5585233 Mutant; gebnetic engineering
12/17/1996US5585098 Injecting fowl hen with immunogen to elicit immunoglobulin antibodies against mastitis-causing organism, administering antibodies to infected lactating ruminant
12/17/1996US5585096 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
12/17/1996US5585095 Method to enhance thrombomodulin APC generation using cationic proteins
12/17/1996US5585093 Cosmetic deodorant compositions containing encapsulated bicarbonate and liquid fragrance ingredients
12/17/1996US5585089 Humanized immunoglobulins
12/17/1996CA2178982A1 Fluoridated micellar casein
12/17/1996CA2013809C Agent for the prophylaxis of atopy and methods for preparing and using same
12/17/1996CA2006684C Monoclonal antibody against protein c
12/16/1996WO1996039508A1 Fibroblast growth factor 13
12/16/1996CA2220988A1 Fibroblast growth factor 13
12/16/1996CA2178894A1 Parathyroid hormone derivatives and their use
12/13/1996CA2178789A1 Hemostyptic and tissue adhesive
12/12/1996WO1996039541A1 Colon specific gene and protein
12/12/1996WO1996039540A1 Novel gene-up regulated in regenerating liver
12/12/1996WO1996039531A1 Delivery of nucleotides into organisms by electroporation
12/12/1996WO1996039524A1 Methods for enhancement of protective immune responses
12/12/1996WO1996039523A2 Bacterial production of hydrophobic polypeptides
12/12/1996WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996WO1996039521A1 Human chemokine beta-13
12/12/1996WO1996039520A1 Human chemokine beta-12
12/12/1996WO1996039519A1 Kunitz type plasma kallikrein inhibitors
12/12/1996WO1996039517A1 The erf genetic locus and its products
12/12/1996WO1996039516A2 Targets for breast cancer diagnosis and treatment
12/12/1996WO1996039515A1 Human vascular endothelial growth factor 2
12/12/1996WO1996039514A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
12/12/1996WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
12/12/1996WO1996039510A1 Chimeric proteins for use in transport of a selected substance into cells
12/12/1996WO1996039509A1 Fibroblast growth factor 15
12/12/1996WO1996039507A1 Fibroblast growth factor 11
12/12/1996WO1996039506A1 Fibroblast growth factor-14
12/12/1996WO1996039504A2 Methods for distinguishing metastatic and non-metastatic cancers, polynucleotides and polypeptides for use therein
12/12/1996WO1996039503A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION
12/12/1996WO1996039501A2 Oligonucleotides specific for human papillomavirus
12/12/1996WO1996039500A2 Oligonucleotides specific for hepatitis c virus
12/12/1996WO1996039499A1 TNF-α RIBOZYMES, TNF-α RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-α RIBOZYMES
12/12/1996WO1996039497A1 Transforming growth factor alpha hi
12/12/1996WO1996039496A1 Use of neuro-derived fetal cell lines for transplantation therapy
12/12/1996WO1996039489A1 Isolation of mammalian hematopoietic stem cells
12/12/1996WO1996039488A1 Process for controlling sialylation of proteins produced by mammalian cell culture
12/12/1996WO1996039486A1 Human ccn-like growth factor
12/12/1996WO1996039485A1 Human hepatoma-derived growth factor-2
12/12/1996WO1996039442A1 G-protein receptor htnad29
12/12/1996WO1996039441A1 Human g-protein receptor hibef51
12/12/1996WO1996039440A1 Human amine receptor
12/12/1996WO1996039439A1 Human g-protein receptor hcegh45
12/12/1996WO1996039438A1 G-protein receptor hibeb69
12/12/1996WO1996039437A1 Human g-protein chemokine receptor hdgnr10
12/12/1996WO1996039436A1 Human g-protein coupled receptor (hetgq23)
12/12/1996WO1996039435A1 Human g-protein receptor hpraj70
12/12/1996WO1996039434A1 Human g-protein receptor hgber32
12/12/1996WO1996039433A1 G-protein parathyroid hormone receptor hltdg74
12/12/1996WO1996039432A1 Avian immunomodulator product and method of making the same
12/12/1996WO1996039431A1 Bone morphogenic protein-10
12/12/1996WO1996039430A1 TGF-β FUSION PROTEINS AND THEIR USE IN WOUND HEALING
12/12/1996WO1996039429A2 Serum protein produced exclusively in adipocytes
12/12/1996WO1996039428A1 Antitumor proteins from rana pipiens oocytes
12/12/1996WO1996039427A1 Ligand-stimulated gene expression
12/12/1996WO1996039426A1 Hypoxia inducible factor-1 and method of use
12/12/1996WO1996039425A2 Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity
12/12/1996WO1996039424A1 Natural killer cell enhancing factor c
12/12/1996WO1996039423A2 A method for increasing the electrotransport flux of polypeptides
12/12/1996WO1996039422A2 Modification of polypeptide drugs to increase electrotransport flux
12/12/1996WO1996039421A1 Human vascular endothelial growth factor 3
12/12/1996WO1996039419A1 Colon specific genes and proteins
12/12/1996WO1996039418A1 Human cystatin e
12/12/1996WO1996039415A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION
12/12/1996WO1996039409A1 Nitrosylated and nitrated superoxide oxidants and reductants
12/12/1996WO1996039407A1 Quinolizinone type compounds
12/12/1996WO1996039196A1 Gene transfer for treating a connective tissue of a mammalian host
12/12/1996WO1996039194A1 Novel cathepsin and methods and compositions for inhibition thereof
12/12/1996WO1996039187A1 Method for treating molluscum contagiosum resulting from hiv infection
12/12/1996WO1996039185A1 Treatment and diagnosis of prostate cancer
12/12/1996WO1996039184A1 THERAPEUTIC SEPSIS TREATMENT USING ANTAGONISTS TO PTHrP
12/12/1996WO1996039183A1 Compositions and methods for targeted delivery of effector molecules
12/12/1996WO1996039182A1 Dual carrier immunogenic construct
12/12/1996WO1996039178A1 A replication-defective adenovirus human type 5 recombinant as a vaccine carrier
12/12/1996WO1996039174A1 Method for rapid enzymatic alcohol removal
12/12/1996WO1996039173A1 A stabilized pharmaceutical formulation comprising growth hormone and lys-gly-asp-ser
12/12/1996WO1996039172A1 Suppressor of hiv replication and transcription
12/12/1996WO1996039171A1 Therapy using lymphotoxin and thrombopoietin
12/12/1996WO1996039170A1 Cartilage induction by bone morphogenetic proteins
12/12/1996WO1996039169A1 Methods and compositions for healing and repair of connective tissue attachment
12/12/1996WO1996039168A1 Method for increasing hdl cholesterol level
12/12/1996WO1996039167A1 Improved compositions and methods for chemodenervation using neurotoxins
1 ... 2748 2749 2750 2751 2752 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 ... 3163